Key result
Subcutaneous implantable cardioverter defibrillators are associated with inappropriate shocks, which can be minimized by proper preimplant screening and specific management algorithms.
Why the study?
Despite the benefits of subcutaneous implantable cardioverter defibrillators, inappropriate shocks remain a frequent clinical problem.
Design
Review
Authors
Loading...
Supports rigorous S-ICD screening in HCM, Brugada, and ARVC; leaves open prospective trials to standardize algorithms.
Proper pre-implant screening and specific management algorithms are essential to minimize inappropriate shocks in patients with S-ICDs, especially in high-risk populations like those with HCM, Brugada syndrome, and ARVC.
Karnik et al. (2018) conducted a review in Inappropriate therapy in subcutaneous implantable cardioverter defibrillators. Subcutaneous implantable cardioverter defibrillators (S-ICDs) was evaluated. Subcutaneous implantable cardioverter defibrillators are associated with inappropriate shocks, which can be minimized by proper preimplant screening and specific management algorithms.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: